David M. Malkin
Impact in
- Genetics top 0.1%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 110
- Cancer-related Molecular Pathways 79
-
- Cancer Genomics and Diagnostics 46
- Co-authors
- Joseph F. Fraumeni (2 shared papers)Stephen Henry Friend (7 shared papers)Frederick P. Li (4 shared papers)Louise C. Strong (4 shared papers)Jayne Kassel (1 shared paper)Michael A. Tainsky (1 shared paper)Farideh Zamaniyan Bischoff (1 shared paper)David H. Kim (1 shared paper)
- Journals
- Pediatric Blood & Cancer (18 papers)Journal of Clinical Oncology (18 papers)Clinical Cancer Research (17 papers)Cancer Research (9 papers)Nature Communications (7 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
David M. Malkin
295 papers receiving 23.9k citations
David M. Malkin's Hit Papers
Peers
Comparison fields: 5 of 166
- Genetics 5.4k
- Cancer Research 5.6k
- Oncology 7.2k
- Neurology 2.5k
- Molecular Biology 10.9k
Countries citing papers authored by David M. Malkin
This map shows the geographic impact of David M. Malkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Malkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Malkin more than expected).
Fields of papers citing papers by David M. Malkin
This network shows the impact of papers produced by David M. Malkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Malkin. The network helps show where David M. Malkin may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Malkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 312 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms Hit paper breakdown → | 1990 | 3060 |
| 2 | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Hit paper breakdown → | 2012 | 2075 |
| 3 | Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency Hit paper breakdown → | 2016 | 707 |
| 4 | Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations Hit paper breakdown → | 2012 | 688 |
| 5 | Comprehensive Analysis of Hypermutation in Human Cancer Hit paper breakdown → | 2017 | 605 |
| 6 | Epigenomic alterations define lethal CIMP-positive ependymomas of infancy Hit paper breakdown → | 2014 | 485 |
| 7 | Medulloblastoma Hit paper breakdown → | 2019 | 466 |
| 8 | 2016 | 408 | |
| 9 | 2017 | 390 | |
| 10 | 2013 | 378 | |
| 11 | 1992 | 328 | |
| 12 | 2011 | 328 | |
| 13 | 2011 | 322 | |
| 14 | 2019 | 311 | |
| 15 | Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. | 2001 | 290 |
| 16 | Signatures of copy number alterations in human cancer Hit paper breakdown → | 2022 | 285 |
| 17 | 2018 | 281 | |
| 18 | 2009 | 278 | |
| 19 | DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies Hit paper breakdown → | 2018 | 273 |
| 20 | 2006 | 267 |
About David M. Malkin
David M. Malkin is a scholar working on Oncology, Cancer Research, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 312 papers that have together received 24.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (79 papers), Cancer Genomics and Diagnostics (46 papers), Epigenetics and DNA Methylation (37 papers), Glioma Diagnosis and Treatment (36 papers), Sarcoma Diagnosis and Treatment (30 papers), Hedgehog Signaling Pathway Studies (26 papers), Childhood Cancer Survivors' Quality of Life (24 papers) and Neuroblastoma Research and Treatments (18 papers). The work is most often cited by research in Genetics (5.4k citations), Cancer Research (5.6k citations), Oncology (7.2k citations), Neurology (2.5k citations) and Molecular Biology (10.9k citations). David M. Malkin has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Joseph F. Fraumeni, Stephen Henry Friend, Frederick P. Li, Louise C. Strong, Jayne Kassel, Michael A. Tainsky, Farideh Zamaniyan Bischoff, David H. Kim, Adam Shlien and Uri Tabori. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.